In this context, we found that tumor-associated PD-1+ trNK cells from MSI CRCs, as well as PD-1– trNK cells from MSI and MSS CRC, were characterized by adequate amounts of activating NK receptors and a moderate but consistent content of perforin/granzyme B, to exert anti-tumor activities. This evidence concerns the gene PRF1 and neoplasm.